Search research articles
Contact Us
Filters
Showing results (151-160 of 175) with videos related to
Page
of 18
Sort By:
Current Medicinal Chemistry
|
July 7, 2011
Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation
A Boumendjel, S Macalou, G Valdameri, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan
O Arnaud, A Boumendjel, A Gèze, et al.
ESMO Open
|
August 29, 2022
Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101
Y Tomita, J Larkin, B Venugopal, et al.
Human Immunology
|
January 8, 2000
HLA-DRB1* and allergy to Parietaria: linkage and association analyses
M D'Amato, A Picardi, T Menna, et al.
Inorganic Chemistry
|
October 21, 2022
Unconventional Pathways to Carbide Phase Synthesis via Thermal Decomposition of UI<sub>4</sub>(1,4-dioxane)<sub>2</sub>
Maryline G Ferrier, Bradley C Childs, Chinthaka M Silva, et al.
Critical Reviews in Oncology/Hematology
|
December 18, 2007
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting
C Gridelli, P Maione, D Amoroso, et al.
ESMO Open
|
April 27, 2023
Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma
J B A G Haanen, J Larkin, T K Choueiri, et al.
Journal of Neurochemistry
|
December 22, 2021
Colony-stimulating factor-1 receptor inhibition attenuates microgliosis and myelin loss but exacerbates neurodegeneration in the chronic cuprizone model
Victoria S B Wies Mancini, Anabella A Di Pietro, Soledad de Olmos, et al.
ESMO Open
|
March 19, 2025
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients
S Gupta, M A Climent Duran, S S Sridhar, et al.
Advances in Wound Care
|
February 15, 2014
Preclinical Models of Wound Healing: Is Man the Model? Proceedings of the Wound Healing Society Symposium
Gayle M Gordillo, Stephanie F Bernatchez, Robert Diegelmann, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 175) with videos related to
Sort By:
Page
of 18
Current Medicinal Chemistry
|
July 7, 2011
Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation
A Boumendjel, S Macalou, G Valdameri, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 11, 2011
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan
O Arnaud, A Boumendjel, A Gèze, et al.
ESMO Open
|
August 29, 2022
Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101
Y Tomita, J Larkin, B Venugopal, et al.
Human Immunology
|
January 8, 2000
HLA-DRB1* and allergy to Parietaria: linkage and association analyses
M D'Amato, A Picardi, T Menna, et al.
Inorganic Chemistry
|
October 21, 2022
Unconventional Pathways to Carbide Phase Synthesis via Thermal Decomposition of UI<sub>4</sub>(1,4-dioxane)<sub>2</sub>
Maryline G Ferrier, Bradley C Childs, Chinthaka M Silva, et al.
Critical Reviews in Oncology/Hematology
|
December 18, 2007
Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an Experts Panel Meeting
C Gridelli, P Maione, D Amoroso, et al.
ESMO Open
|
April 27, 2023
Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma
J B A G Haanen, J Larkin, T K Choueiri, et al.
Journal of Neurochemistry
|
December 22, 2021
Colony-stimulating factor-1 receptor inhibition attenuates microgliosis and myelin loss but exacerbates neurodegeneration in the chronic cuprizone model
Victoria S B Wies Mancini, Anabella A Di Pietro, Soledad de Olmos, et al.
ESMO Open
|
March 19, 2025
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients
S Gupta, M A Climent Duran, S S Sridhar, et al.
Advances in Wound Care
|
February 15, 2014
Preclinical Models of Wound Healing: Is Man the Model? Proceedings of the Wound Healing Society Symposium
Gayle M Gordillo, Stephanie F Bernatchez, Robert Diegelmann, et al.
Page
of 18